¥í¥°¥¤¥ó
¥á¥¤¥ó¥á¥Ë¥å¡¼


logo

¥ê¥ó¥¯½¸



  ¥á¥¤¥ó  |  ÅÐÏ¿¤¹¤ë  |  ¿Íµ¤¥µ¥¤¥È (top10)  |  ¹âɾ²Á¥µ¥¤¥È (top10)  |  ¤ª¤¹¤¹¤á¥µ¥¤¥È (7)  |  Áê¸ß¥ê¥ó¥¯¥µ¥¤¥È (1)  

  ¥«¥Æ¥´¥ê°ìÍ÷  |  RSS/ATOM Âбþ¥µ¥¤¥È (18)  |  RSS/ATOM µ­»ö (66978)  |  ¥é¥ó¥À¥à¥¸¥ã¥ó¥×  

RSS/ATOM µ­»ö (66978)

¤³¤³¤Ëɽ¼¨¤µ¤ì¤Æ¤¤¤ë RSS/ATOM µ­»ö¤ò RSS ¤È ATOM ¤ÇÇÛ¿®¤·¤Æ¤¤¤Þ¤¹¡£


rss  atom 

ÊÆSana¼Ò¡¢ÌȱÖÍÞÀ©ÎÅË¡ÉÔÍפÎç¹ÅçºÙ˦°Ü¿¢¤ò1·¿ÅüǢɴµ¼Ô¤ËŬÍѤ·¤¿»î¸³¤Ç¹¥·ë²Ì  from Æü·Ð¥Ð¥¤¥ª¥Æ¥¯ONLINE  (2025-7-2 7:00) 
¡¡ÊÆSana Biotechnology¡Ê¥µ¥Ê¡¦¥Ð¥¤¥ª¥Æ¥¯¥Î¥í¥¸¡¼¡Ë¼Ò¤Ï2025ǯ6·î23Æü¡¢Æ±¼ÒÀìÍ­¤ÎHIP¡ÊHypoimmune¡§ÄãÌȱֲ½¡Ëµ»½Ñ¤òŬÍѤ·¤¿Æ±¼ï°Û·Ï¤Îç¹ÅçͳÍè½éÂåºÙ˦UP421¤ò½é¤á¤Æ¥Ò¥È¤Î´µ¼Ô¤ËŬÍѤ·¤¿¡¢¸¦µæ¼Ô¼çƳ¤ÎÎ×¾²»î¸³¤Î6¥«·î´Ö¤Î·ë²Ì¤¬¡¢Êƹñ¥·¥«¥´¤Ç³«ºÅ¤µ¤ì¤¿ÊÆÅüǢɳزñ¡ÊADA¡ËÂè85²ó³Ø½Ñ½¸²ñ¡ÊADA2025¡Ë¤Î¾·ÂÔ¹Ö±é¤ÇÊó¹ð¤µ¤ì¤¿¤³¤È¤òÌÀ¤é¤«¤Ë¤·¤¿¡£
DTC°äÅÁ»Ò¸¡ºº¤ÎÊÆ23andMe¼Ò¡¢Çã¼ýÀ褬¸µCEO¤ÎAnne Wojcicki»áΨ¤¤¤ëÈó±ÄÍø¸ø±×Ë¡¿Í¤ËÊѹ¹  from Æü·Ð¥Ð¥¤¥ª¥Æ¥¯ONLINE  (2025-7-2 7:00) 
¡¡2025ǯ3·î¤«¤éÇË»º¼ê³¤­¤ò¹Ô¤Ã¤Æ¤¤¤ë°ìÈ̾ÃÈñ¼Ô¸þ¤±¡ÊDirect to Cosumer¡§DTC¡Ë°äÅÁ»Ò¸¡ºº¤ÎÊÆ23andMe¡Ê¥È¥¥¥¨¥ó¥Æ¥£¡¼¥¹¥ê¡¼¡¦¥¢¥ó¥É¡¦¥ß¡¼¡Ë¼Ò¤¬¡¢ÇË»º¼ê³¤­³«»ÏÁ°¤Þ¤ÇƱ¼Ò¤ÎCEO¤ò̳¤á¤Æ¤¤¤¿Anne Wojcicki»á¤¬½êŤò̳¤á¤ëÈó±ÄÍø¸ø±×Ë¡¿Í¤ÎTTAM Research Institute¤ËÇã¼ý¤µ¤ì¤ë¤³¤È¤Ë¤Ê¤Ã¤¿¡£Æ±Ç¯5·î¤Ë¤ÏÊÆRegeneron Pharmaceuticals¡Ê¥ê¥¸¥§¥Í¥í¥ó¡¦¥Õ¥¡¡¼¥Þ¥·¥å¡¼¥Æ¥£¥«¥ë¥º¡Ë¼Ò¤¬Çã¼ý¤¹¤ë¤Èȯɽ¤·¤Æ¤¤¤¿¤¬¡¢Çã¼ýÀ褬Êѹ¹¤Ë¤Ê¤Ã¤¿¡£
CiRA¡¦óîÆ£Çî±Ñ¶µ¼ø¡¢ºÙ˦½ã²½¤Ê¤É¸þ¤±¤ÎRNA¥¹¥¤¥Ã¥Á¤ò²þÎɤ·ÆÃ°ÛÀ­¤ò¸þ¾å  from Æü·Ð¥Ð¥¤¥ª¥Æ¥¯ONLINE  (2025-7-2 7:00) 
¡¡µþÅÔÂç³ØiPSºÙ˦¸¦µæ½ê¡ÊCiRA¡Ë/ÅìµþÂç³ØÄêÎÌÀ¸Ì¿²Ê³Ø¸¦µæ½ê¡ÊIQB¡Ë¤ÎóîÆ£Çî±Ñ¶µ¼ø¡¢CiRA¤ÎÂçÌîÇîµ×½õ¶µ¡¢µþÅÔÂçÂç³Ø±¡°å³Ø¸¦µæ²Ê/ÅìµþÂçIQB¤Î°¤Éô°ì¼ùÂç³Ø±¡À¸¤é¤Î¸¦µæ¥Á¡¼¥à¤Ï¡¢¥Þ¥¤¥¯¥íRNA¡ÊmiRNA¡Ë¤òÍøÍѤ·¤ÆÌÜŪ¤ÎºÙ˦¤Ç°äÅÁ»Òȯ¸½¤òÀ©¸æ¤¹¤ë¡ÖRNA¥¹¥¤¥Ã¥Á¡×¤ò²þÎɤ·¤¿¡£Ê£¿ô¤ÎmiRNA¤ò»È¤Ã¤Æ¥¹¥¤¥Ã¥Á¤ò¥ª¥ó¥ª¥Õ¤¹¤ë¤³¤È¤Ç¡¢½¾Íè¤è¤ê¤âÆÃ°ÛÀ­¹â¤¯RNA¥¹¥¤¥Ã¥Á¤òºîÍѤµ¤»¤é¤ì¤ë¤è¤¦¤Ë¤Ê¤Ã¤¿¡£ÏÀʸ¤¬2025ǯ7·î1Æü¡¢Nature Communications»ï¤Ë¥ª¥ó¥é¥¤¥ó·ÇºÜ¤µ¤ì¤¿¡£
ÊÆVertex¼Ò¡¢1·¿ÅüǢɤؤξ²È´´ºÙ˦ͳÍè¤Îç¹ÅçºÙ˦ÎÅË¡¤ÎÂè1/2Áê¤Ç¹¥·ë²Ì  from Æü·Ð¥Ð¥¤¥ª¥Æ¥¯ONLINE  (2025-7-1 7:00) 
¡¡ÊÆVertex Pharmaceuticals¡Ê¥Ð¡¼¥Æ¥Ã¥¯¥¹¡¦¥Õ¥¡¡¼¥Þ¥·¥å¡¼¥Æ¥£¥«¥ë¥º¡Ë¼Ò¤Ï2025ǯ6·î20Æü¡¢Â¾²È´´ºÙ˦ͳÍè¤Î´°Á´Ê¬²½·¿ç¹ÅçºÙ˦ÎÅË¡¤Ç¤¢¤ëzimislecel¡Ê³«È¯Èֹ桧VX-880¡Ë¤ò¡¢Äã·ìÅü¤ò¼«³Ð¤·¤Ë¤¯¤¯¡¢½Å¾ÉÄã·ìÅü¥¤¥Ù¥ó¥È¡ÊSHE¡Ë¤ò·Ð¸³¤·¤Æ¤¤¤ë1·¿ÅüǢɡÊT1D¡Ë´µ¼Ô¤ËŬÍѤ·¤¿¡¢Âè1/2/3ÁêÎ×¾²»î¸³¡ÊFORWARD-101¡Ë¤ÎÂè1/2ÁêÉôʬ¤ÎºÇ¿·¥Ç¡¼¥¿¤¬¡¢Êƹñ¥·¥«¥´¤Ç³«ºÅ¤µ¤ì¤¿ÊÆÅüǢɳزñ¡ÊADA¡ËÂè85²ó³Ø½Ñ½¸²ñ¡ÊADA2025¡Ë¤Ç¸ýƬȯɽ¤µ¤ì¤¿¤³¤È¤òÌÀ¤é¤«¤Ë¤·¤¿¡£Êó¹ð¤µ¤ì¤¿¥Ç¡¼¥¿¤ò¤Þ¤È¤á¤¿ÏÀʸ¤Ï¡¢New England Journal of Medicine¡ÊNEJM¡Ë»ï¤ÇƱ»þ¸ø³«¤µ¤ì¤¿¡£
ÂçºåÂ硦̾¸Å²°Â硦NIBN¡¢Ê¢ËìÇżï¤òȼ¤¦°ß¤¬¤ó¤ËÂФ¹¤ë¥¢¥ó¥Á¥»¥ó¥¹³Ë»À¤ÎÂè1Áê°å»Õ¼çƳ¼£¸³¤ò³«»Ï  from Æü·Ð¥Ð¥¤¥ª¥Æ¥¯ONLINE  (2025-7-1 7:00) 
¡¡ÂçºåÂç³Ø¤È̾¸Å²°Âç³Ø¡¢°åÌô´ðÈס¦·ò¹¯¡¦±ÉÍܸ¦µæ½ê¡ÊNIBN¡Ë¤Ï2025ǯ6·î30Æü¡¢Ê¢¹ÐÆâ¤Ë¤¬¤óºÙ˦¤¬»¶¤é¤Ð¤Ã¤ÆÅ¾°Ü¤¹¤ëÊ¢ËìÇżï¤òȼ¤¦°ß¤¬¤ó¤Î´µ¼Ô¤òÂоݤȤ·¤Æ¡¢¿·µ¬¤Î¥¢¥ó¥Á¥»¥ó¥¹³Ë»À¡ÊASO¡Ë¤ÎÂè1Áê°å»Õ¼çƳ¼£¸³¤ò³«»Ï¤·¤¿¤Èȯɽ¤·¤¿¡£¹³¤¬¤óÌô¤Ê¤É´û¸ÎÅË¡¤Ç¤Î¼£ÎŤ¬Æñ¤·¤¤Ê¢ËìÇżï¤Î¤¢¤ë´µ¼Ô¤òÂоݤˡ¢synaptotagmin 13¡ÊSYT13¡Ë°äÅÁ»Ò¤òɸŪ¤È¤·¤¿ASO¤ÎASO-4733¡Ê³«È¯ÈÖ¹æ¡Ë¤òÅêÍ¿¤¹¤ë¡£
Lilly¼Ò¡¢ÊÆVerve¼ÒÇã¼ý¤Ç¿´·ì´É¥ê¥¹¥¯¤Î¹â¤¤´µ¼Ô¸þ¤±°äÅÁ»ÒÊÔ½¸ÎÅË¡¤Î³«È¯¿ä¿Ê  from Æü·Ð¥Ð¥¤¥ª¥Æ¥¯ONLINE  (2025-7-1 7:00) 
¡¡ÊÆEli Lilly and Company¡Ê¥¤¡¼¥é¥¤¥ê¥ê¡¼¡¦¥¢¥ó¥É¡¦¥«¥ó¥Ñ¥Ë¡¼¡Ë¼Ò¤Ï2025ǯ6·î17Æü¡¢¿´·ì´ÉÂå¼Õ¼À´µ¤ËÂФ¹¤ëin vivo°äÅÁ»ÒÊÔ½¸ÎÅË¡¤ò³«È¯¤·¤Æ¤¤¤ëÊÆVerve Therapeutics¡Ê¥ô¥¡¡¼¥ô¡¦¥»¥é¥Ô¥å¡¼¥Æ¥£¥¯¥¹¡Ë¼Ò¤ÎÇã¼ý¤Ë´Ø¤¹¤ëÀµ¼°·ÀÌó¤òÄù·ë¤·¤¿¤Èȯɽ¤·¤¿¡£
Spiber¡¢ÃÁÇò¼Á¤ÎÀ¸»ºÀ­¸þ¾å¤Ê¤É¼õ¤±¡¢·úÀßͽÄê¤ÎÎÌ»º¥×¥é¥ó¥È¤Ï¾®µ¬Ìϲ½¤ÎÊý¿Ë  from Æü·Ð¥Ð¥¤¥ª¥Æ¥¯ONLINE  (2025-7-1 7:00) 
¡¡ÈùÀ¸ÊªÈ¯¹Ú¤ÇÀ¸»º¤·¤¿ÃÁÇò¼Á¤ò»ö¶È²½¤·¤Æ¤¤¤ëSpiber¡Ê»³·Á¸©ÄᲬ»Ô¡¢´Ø»³Ï½¨¼èÄùÌò·óÂåɽ¼¹¹ÔÌò¡Ë¤¬¡¢ÃÁÇò¼Á¤ÎÎÌ»º²½·×²è¤òÊѹ¹¤¹¤ë¸«Ä̤·¤À¡£°ÙÂØ¤Î±Æ¶Á¤äʪ²Á¾å¾º¤Ç·úÀßÈñ¤¬ËĤé¤ó¤À¤³¤È¤ä¡¢ÃÁÇò¼Á¤ÎÀ¸»ºµ»½Ñ¤Î²þÎɤÇÀ¸»ºÀ­¤¬¹â¤Þ¤Ã¤¿¤³¤È¤Ê¤É¤ò¼õ¤±¡¢Êƹñ¤Ë·úÀßͽÄê¤ÎÎÌ»º¥×¥é¥ó¥È¤ò·×²èÅö½é¤è¤ê¤â¾®µ¬ÌϤˤ¹¤ëÊý¿Ë¤ò¼è¤ë¡£2025ǯ6·î24Æü¡¢Æ±¼Ò¤Î´Ø»³Ï½¨¼èÄùÌò·óÂåɽ¼¹¹ÔÌò¤¬ËÜ»ï¤Î¼èºà¤Ë±þ¤¸¡¢º£¸å¤Î»ñ¶â·«¤ê¤äÀßÈ÷Åê»ñ¤Î·×²è¤Ë¤Ä¤¤¤Æ¸ì¤Ã¤¿¡£
ÆÃ½¸¡ý¹ñÆâÀ½Ìô´ë¶È¤Î¥Ñ¥¤¥×¥é¥¤¥óʬÀÏ2025¡Ú´ë¶ÈÊԡۡʤ½¤Î2¡Ë¡¢Âè°ì»°¶¦¡¢ÂçÄÍHD¡¢Ãæ³°À½Ìô¤Î¥Ñ¥¤¥×¥é¥¤¥  from Æü·Ð¥Ð¥¤¥ª¥Æ¥¯ONLINE  (2025-7-1 7:00) 
¡¡¡Ö¹ñÆâÀ½Ìô´ë¶È¤Î¥Ñ¥¤¥×¥é¥¤¥óʬÀÏ2025¡×¤«¤é¡¢Âè°ì»°¶¦¡¢ÂçÄÍ¥Û¡¼¥ë¥Ç¥£¥ó¥°¥¹¡ÊHD¡Ë¡¢Ãæ³°À½Ìô¤Î¥Ñ¥¤¥×¥é¥¤¥ó¤ò²òÀ⤹¤ë¡£Âè°ì»°¶¦¤Ï¤¬¤ó¤Î¥×¥í¥¸¥§¥¯¥È¤¬ÂçÉý¤ËÁý²Ã¡£ÂçÄÍHD¤Ï¤¬¤óµÚ¤Ó¿À·Ð¡¦Àº¿ÀÎΰè¤Ç¥é¥¤¥Õ¥µ¥¤¥¯¥ë¥Þ¥Í¥¸¥á¥ó¥È¤ò¿Ê¤á¤Æ¤ª¤ê¡¢Ãæ³°À½Ìô¤Ï¿¤¯¤Î¿½ÅÆÃ°ÛÀ­¹³ÂθõÊä¤òÊÝÍ­¤·¤Æ¤¤¤ë¡£
¥ß¥È¥³¥ó¥É¥ê¥¢É¤μ£ÎÅÌô³«È¯¤¹¤ëÊÆTisento¼Ò¡¢sGC³èÀ­²½Ìô¤¬FDA¤«¤é¥Õ¥¡¥¹¥È¥È¥é¥Ã¥¯»ØÄê  from Æü·Ð¥Ð¥¤¥ª¥Æ¥¯ONLINE  (2025-6-30 7:00) 
¡¡¥ß¥È¥³¥ó¥É¥ê¥¢É¤μ£ÎÅÌô³«È¯¤ò¼ê³Ý¤±¤Æ¤¤¤ëÊÆTisento Therapeutics¡Ê¥Æ¥£¥»¥ó¥È¡¦¥»¥é¥Ô¥å¡¼¥Æ¥£¥¯¥¹¡Ë¼Ò¤Ï2025ǯ6·î17Æü¡¢²ÄÍÏÀ­¥°¥¢¥Ë¥ë»À¥·¥¯¥é¡¼¥¼¡ÊsGC¡Ë¤ò³èÀ­²½¤¹¤ë1Æü1²ó¤Î·Ð¸ýÌô¡Ê°ìÈÌ̾¡§zagociguat¡¢³«È¯Èֹ桧CY-6463¡Ë¤¬¡¢MELAS¡ÊMitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes¡§¥ß¥È¥³¥ó¥É¥ê¥¢Ç¾¶Ú¾É¡¦Æý»À¥¢¥·¥É¡¼¥·¥¹¡¦Ç¾Â´ÃæÍÍ¥¨¥Ô¥½¡¼¥É¡Ë¤ÎŬ±þ¤ÇÊÆ¿©ÉʰåÌôÉʶɡÊFDA¡Ë¤«¤é¥Õ¥¡¥¹¥È¥È¥é¥Ã¥¯¤Ë»ØÄꤵ¤ì¤¿¤Èȯɽ¤·¤¿¡£Æ±¼Ò¤Ï¸½ºß¡¢Âè2bÁêÎ×¾²»î¸³¡ÊPRIZM»î¸³¡Ë¤Î´µ¼ÔÅÐÏ¿¤ò¿Ê¤á¤Æ¤¤¤ë¡£
J¡õJ¼Ò¡¢GPRC5DxCD3µÚ¤ÓBCMAxCD3¤ÎÆó½ÅÆÃ°ÛÀ­¹³ÂÎÊ»ÍѤ¬Â¿È¯À­¹ü¿ñ¼ð¤ÎÂè2Áê¤Ç¹¥·ë²Ì  from Æü·Ð¥Ð¥¤¥ª¥Æ¥¯ONLINE  (2025-6-30 7:00) 
¡¡ÊÆJohnson¡õJohnson¼Ò¡Ê¥¸¥ç¥ó¥½¥ó¡¦¥¨¥ó¥É¡¦¥¸¥ç¥ó¥½¥ó¡¢J¡õJ¡Ë¤Ï2025ǯ6·î15Æü¡¢¤¤¤º¤ì¤â¿ȯÀ­¹ü¿ñ¼ð¤òŬ±þ¤È¤·¤ÆÊÆ¿©ÉʰåÌôÉʶɡÊFDA¡Ë¤Î¾µÇ§¤òÆÀ¤Æ¤¤¤ë¡¢GPRC5D¡ÊGÃÁÇò¼Á¶¦Ìò·¿¼õÍÆÂÎ¥Õ¥¡¥ß¥ê¡¼C¥°¥ë¡¼¥×5¥á¥ó¥Ð¡¼D¡Ë¤ÈCD3¤òɸŪ¤È¤¹¤ëÆó½ÅÆÃ°ÛÀ­¹³ÂΡÖTALVEY¡×¡Êtalquetamab-tgvs¡Ë¤È¡¢BCMA¡ÊBºÙ˦À®½Ï¹³¸¶¡Ë¤ÈCD3¤òɸŪ¤È¤¹¤ëÆó½ÅÆÃ°ÛÀ­¹³ÂΡÖTECVAYLI¡×¡Êteclistamab-cqyv¡Ë¤òÊ»ÍѤ·¤¿¡¢Âè2ÁêÎ×¾²»î¸³¡ÊRedirecTT-1»î¸³¡Ë¤Î¿·¤¿¤Ê¥Ç¡¼¥¿¤¬¡¢¥¤¥¿¥ê¥¢Milan¤Ç³«ºÅ¤µ¤ì¤¿²¤½£·ì±Õ³Ø²ñ ¡ÊEHA¡Ë2025ǯ¼¡Áí²ñ¤ÎLate-Breaking±éÂê¤È¤·¤Æ¸ýƬȯɽ¤µ¤ì¤¿¤³¤È¤òÌÀ¤é¤«¤Ë¤·¤¿¡£



« 1 2 3 4 5 (6) 7 8 9 10 11 [6698] »